Leap Therapeutics Announces Completion of Enrollment in Part B of the Defiance Study of Dkn-01 for the Treatment of Colorectal Cancer Patients
leap therapeutics宣佈完成Dkn-01治療結直腸癌患者的Defiance研究b部分的招募。
Leap Therapeutics Announces Completion of Enrollment in Part B of the Defiance Study of Dkn-01 for the Treatment of Colorectal Cancer Patients
leap therapeutics宣佈完成Dkn-01治療結直腸癌患者的Defiance研究b部分的招募。
譯文內容由第三人軟體翻譯。